{"name":"Duchesnay Inc.","slug":"duchesnay-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2013-01-01","label":"Osphena first approved","drug":"Osphena","drugSlug":"ospemifene","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Bonjesta","genericName":"Bonjesta","slug":"bonjesta","indication":"Other","status":"marketed"},{"name":"Diclegis","genericName":"Diclegis","slug":"diclegis","indication":"Other","status":"marketed"},{"name":"Osphena","genericName":"OSPEMIFENE","slug":"ospemifene","indication":"Atrophic vulva","status":"marketed"}]}],"pipeline":[{"name":"Bonjesta","genericName":"Bonjesta","slug":"bonjesta","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Diclegis","genericName":"Diclegis","slug":"diclegis","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Osphena","genericName":"OSPEMIFENE","slug":"ospemifene","phase":"marketed","mechanism":"Osphena works by binding to estrogen receptors, specifically targeting estrogen receptor beta, to provide relief from symptoms of atrophic vulva and dyspareunia.","indications":["Atrophic vulva","Dyspareunia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQYWIzWGRmRTBMcURqSEYybkVweFp2ZFlkblNjajNJOUdTX1BZRmhPUFdmSEt2Rl9sUm80bzRxZHNwSlRDZ25QVkFRXzhXRFFwWFhoeUNhTVVRc05MQWQ2emhramRPWUpxdWRsLWk5bzlFZUF2Y0NxQU1raVJZNjRNeVVqQVZQcVFaWkxkTlZQTWFYaWRTWDBSNjNwRGVWZ0tJc1BGVHkyMFBHSHJVdnFIVUZwTHZIREo1aTBrSFNrdFlPT0dYUzgw?oc=5","date":"2026-04-08","type":"pipeline","source":"BioSpace","summary":"Duchesnay launches a contraceptive vaginal system that can be used for up to a full year - BioSpace","headline":"Duchesnay launches a contraceptive vaginal system that can be used for up to a full year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNeUJINk1VaE1JbE9lWERvMlJaeGlnVHU1QVJWWDhfZk0wM05UdWxadGRkQ2gtUDR3TWM4Q3owNy03NTRHUER2M2FpbnY2bEJ4TGJsYVlqX1NOU0dCWTNmOFlfcldLMlhsbi1mNXo1cUF3VC16Tk1LRV9tekJ0Qy05NDk2enJrSjZmVmQzRkY0bHRtUkdsUmYtTFQ3VWpoRWNweGRCOEdwdU45WHNQM0k2a2NhRW93TVJudFJwUGhtZlJmRVVITkRzRmVUbDZmY2MzSkw2OVJncW9lR2NlbUh4TjltQy1Vc2J5WUVlQ25iVkcwX3pwRjBiLXBCaFYtVEQ2QjRKZUVrMTMzOVk?oc=5","date":"2025-12-15","type":"deal","source":"BioSpace","summary":"Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan - BioSpace","headline":"Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the is","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQTEtPVGRnbFliV1g1Vi1veGIwdzY0dGp0bHZnVlhsMk1BUk8tVmU2UkxudUQtSHhQdkFNUTRkcTFJVUlMdERXYjB3c1NTNTc3M0stbm5TRkxuOVFxcC1wNUphX3BpcUNBLVN2ZnROVkFoVmFoNzFaMkQ4aU4ydGthN0ZrcHNrVDhsYkRwSDRTak1TTFhfT1lDYlJMRjlEMGZEb2hKSEJuUUtyYmVQNGQxMm4yVUZaNnd1SFNETkRETmt2MVp1bHdXUjJNNHFaQzFEV29CMGRnNDdVR0lNQjRB?oc=5","date":"2025-09-16","type":"pipeline","source":"Canadian Manufacturing","summary":"Duchesnay Pharmaceutical Group Implements A Second Shift To Expand Production Capacity - Canadian Manufacturing","headline":"Duchesnay Pharmaceutical Group Implements A Second Shift To Expand Production Capacity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQV0VFX2hJWkNHUFVDRHpXN19Ca2NTdFdGeFlnc0lwZ1hxR3ZSQkVNZHdPWmZwa1lFdTV4R3NlcXh6MS1rdEEzNGduZUF6NWxLUjVtV1pYMHBkbkJBcHMwUkpyOHRocjl4cW5pLU9aWFRuVkhiS3NpT0x4LVFaUXFmOGlzNkh0eHBac1UtTlg2TVpaaDc0MjkzeUhtTVZOMWNONW8wakxfMkRENGloclJWeE9fbm1hSlJBX3l1aGtSMFYzTF9QSkdsVHdjTFNKbXRKQXFQYjhMRWh2R3dkU190alUtWl8wMlcwQ1J1XzBkcXBxQVN0eGlGVHJpSGJRTUI2M3lBbzFIWQ?oc=5","date":"2025-09-16","type":"regulatory","source":"prnewswire.com","summary":"Duchesnay Pharmaceutical Group implements a second shift to expand its production capacity to meet growing global demand - prnewswire.com","headline":"Duchesnay Pharmaceutical Group implements a second shift to expand its production capacity to meet growing global demand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxOWjRHVkxBWndNNHh4cWVXOFltNzRXRDhYdVEwLV84N2NyOTZEUHRiX3N6d3E4OW12ZjJidk5QNnMyZ0oxZHBYVzVpSTY5bmpOZ1Vqd0o5cVVqOUNKaEtGbmR4QUJ6akRSWm1ySmtjeDdTTEFBUUUzUWotdzJ3bkptRUJBZTR4WU5RcUU4YkdrQTY5NVZrUGNmU2ZMVG5IVE94SklWbnZVTmdnbDFTXzZTdUNpX293UWFJcUpPZ3pqZ3FtSEdoUExMc01PRGhrMklmakM4azFpeUY2T1N1OVBzdm5ONzc2WE1UVE9BNHU4ZndENU1BdXNZRGowZVJkZzYycVNCOVJSSGRyUDFzTjlCOWZwRW9NM3pSYzhUUk9sYXIwQktHbWNKX2h1Qy02b3JXamdmM0dIMzl5YktZV1B5blRuU2lfZw?oc=5","date":"2025-06-17","type":"pipeline","source":"prnewswire.com","summary":"Duchesnay Pharmaceutical Group accelerates global growth with innovative technology supported by Investissement Québec's grand V initiative and the Government of Quebec - prnewswire.com","headline":"Duchesnay Pharmaceutical Group accelerates global growth with innovative technology supported by Investissement Québec's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNLUU4cUVod1J0RV9aOG1rancwWHd1bXdkX0hTQkZYWG81TmtqendmeHAtVlptN2lCYngwU0FadkRrcTh6SXo4eE9EYUxNR29PUVlIUG1EUkJ5cjNzNGRXNVhNc1hhTWFnZTJEUGdqa25FcVk4QlZyaFVJRGZmMWcyMDYtZFpnWWgxekdJVENpLU1McF96TzR3MTJFQjNLV29OcTJOQmFmMVFLUnZBdTVxd1hRMU1kU0kzUS1TdHI1RXdEeERocTNrX0F3eDJOVXRnUER4dk90NDVGYUh2Y2E2STRKVlN6ajZQUXFmNTdRREh0NmtueS1SVTdNUVFpOXM5NUFB?oc=5","date":"2025-05-29","type":"trial","source":"Newswire Canada","summary":"A joint study by Duchesnay and PeriPharm exposes critical gaps in access to innovative women's health products in Canada - Newswire Canada","headline":"A joint study by Duchesnay and PeriPharm exposes critical gaps in access to innovative women's health products in Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNOUZ5bmVjVUVwU0ZVd25wS2ljSGtlSzBKVlNEdTBYODkwSXRyemVscWpHQVplNzhWcGo3Sk5ublFaTmxJd1JJYUdTRTh0VjdBSDZWQjFVZDZaNVpsOW14R25oeUR6Ujg0WjYwZjJnRVFqcFdCQkdfYnNXSjhnNFZZNXk5VmJzMkxVYkltaUNhVklfU3NuejBpN29WaWRDU0NWLXNqaWZja0FiWG5XbmFKTFo2NzFwaktjU2I3eWRtQUVqUXJSYVpJcVBYS1RzVmtvM0ZadEI5c3U3eUF3Ym9fY19aWmdlUQ?oc=5","date":"2025-04-15","type":"pipeline","source":"Newswire Canada","summary":"Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group's growth and success - Newswire Canada","headline":"Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group's growth and success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxNMm9EY0Q3RXZfZzFOczZKZTQ1WnNkNzVQU2xWMXZkWERnNERSUThrc2hyYktFcHMtVkI4NnBFSXBRR0NxQ1l3LWJCREZZdmdPcUJ1dW42WkpkdjVLRW1QT3FKWTFDUEc4alB5Y3Bpa1FRUzI3UzZQc2Y4MHRkN0k2Zlc1b3VSOEt2Um1Yb2RuazBLVnRvdEJtNzJyLXZVWjdsVnJnX0dSbEYzUWhpM0dsaW8ybklTM3lPQ3QyUGNwcndPT3NmWTV2eUFSTkFna1lkcmM5dnNUdmR2Q0VYaG5Ub2k2Q0h0dzZFWHFuWF9fQm9zX0ZqSWJUUTY4Nk9mSzRrNGJhZ2VZdkVHQTFSQ3JDOTZ4LUZVT2c?oc=5","date":"2025-03-27","type":"pipeline","source":"prnewswire.com","summary":"Duchesnay Pharmaceutical Group recognized for commitment to well-being of its employees as winner of 2025 Healthiest Workplace Award - prnewswire.com","headline":"Duchesnay Pharmaceutical Group recognized for commitment to well-being of its employees as winner of 2025 Healthiest Wor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPT2s0WkpXQ09PQ0RoTHNyUDVmZjUtcEtiUVVnRXFGd3ZSQzFQVndKT2kxaGVXVDQ5Qk9VUllPMkd6Y2w4czE4eG1sbTFuU0V1Qml6Ml9VOXlteFBpQldDMkJDTlh2WmlxV01RelE2Z2hfMDR3TVVqTC1EQTVwbWRpSzVuZmUzQVNOVkRTZ2l4ZFJ3X0p1TVlfdm5PZWczd3NYamVfME5MaVBEMjgzUWFvdVhWQ0J5VzBubG05WDVMQ1ZoOXozNmVDNTY4blBaX2ZKTkZMSW83ZHJlUHFHZkFvYlhuYU1iVUhyX2RpazNSWThGa3QteVRBR0h1c2k?oc=5","date":"2023-11-30","type":"regulatory","source":"BioSpace","summary":"Duchesnay Inc. is seeking Health Canada approval for a segesterone acetate/ethinyl estradiol contraceptive vaginal system, a new option for women - BioSpace","headline":"Duchesnay Inc. is seeking Health Canada approval for a segesterone acetate/ethinyl estradiol contraceptive vaginal syste","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxNOHBlNVVRSlg4c0dKekhzZ0Z0VEpZeGNyXzM1b0NjMGhHTVNzMDRoY0gwc1JNYTFHMU8yMGUxbjNBT0JjUGhPZnZGdmctM3FDa2xvcDVyYllhR3RNLVZEZ0lLY3MwaXVwT1lDSHlhZW9QaVZlMXJsbzlORmswWklpRlU1WmFXTThKeFRqVTV0V0dWQVJZUjBtYUxGdzJMdU1EakszMHRoS0pySVVBbXM2UXBmdjZvOWRtdTJGYWNuUjhUTlpLYmRjN1hhaXVfcmNXU1RISV9tVU5nV2NCd2JvdG55NVVySHFMVDBsWGJPaUFybDQ?oc=5","date":"2023-07-12","type":"pipeline","source":"GlobeNewswire","summary":"Slynd® (drospirenone) is now covered by the Régie de l’assurance maladie du Québec - GlobeNewswire","headline":"Slynd® (drospirenone) is now covered by the Régie de l’assurance maladie du Québec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPczliSXNfdXBjNjRXODRmYWVySnVpdFdaV21tSHR3djAtNEdMUlBKTVBRYVVoWUhPTVZmTXM5Uk5GYmQzckpfVmlTVU9jQnFaN2VYYldfY2tWVGtEYkdSUDcxTG5MZTBTU1p1aXU5d2xGNURrNGljRnZRRjNPS1NqV0tEZExjSWpoVDZpOGpESmh1di1UdXRFSHZ4VmNyc0p6UmpkbUpYUnN1WVh4OU5mYl9uSlVINzZfLVBxLUJ2S3lkZ1pxNVEyOEFVQ2hVei1JNFRzVFJPUFJ5b0d6bGJ2Q2xxaHpmUExmQmhRQ1hCaUQzRVpzWm9fM2FfemJxb21Fa3VfWlZ0bk1XZUVyY0JaaGJXd2x6VlY4NTRFWURFb1FsZ0p4MkdlbHU3d2U4TTBEUnRIbVJONzZTNXJw?oc=5","date":"2022-06-21","type":"pipeline","source":"GlobeNewswire","summary":"Duchesnay announces the launch of Vablys® (dequalinium - GlobeNewswire","headline":"Duchesnay announces the launch of Vablys® (dequalinium","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOSTRYcklXS2lybzdTbmhsWFZRbDBrUnVYM1YwS25FRDR0ZFpmX0t6RGhLcGQySEtRb2NxVGRaTUdQQUNuVjJMQlkyTUs3aFZFRnFocURvaExNZ3dTX1VYX203c1BVRFF4Q0RJTkZyT3ZCai1xNDZWTFZIeTZtSHAzd1BER3VXS2hEbFRRS2J5LS1kbFRqMTJMYnA0UHV5ZnJYVnc5d1Zn?oc=5","date":"2015-08-12","type":"regulatory","source":"BioPharma Dive","summary":"FDA chastizes Duchesnay, Kim Kardashian over drug promo posts - BioPharma Dive","headline":"FDA chastizes Duchesnay, Kim Kardashian over drug promo posts","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}